Search results for "Epigenetic changes"

showing 5 items of 5 documents

Involvement of TLR4 in the long-term epigenetic changes, rewarding and anxiety effects induced by intermittent ethanol treatment in adolescence

2016

Studies in humans and experimental animals have demonstrated the vulnerability of the adolescent brain to actions of ethanol and the long-term consequences of binge drinking, including the behavioral and cognitive deficits that result from alcohol neurotoxicity, and increased risk to alcohol abuse and dependence. Although the mechanisms that participate in these effects are largely unknown, we have shown that ethanol by activating innate immune receptors, toll-like receptor 4 (TLR4), induces neuroinflammation, impairs myelin proteins and causes cognitive dysfunctions in adolescent mice. Since neuroimmune signaling is also involved in alcohol abuse, the aim of this study was to assess whethe…

Male0301 basic medicineEpigenetic changesmedia_common.quotation_subjectImmunologyRewarding effectsAlcohol abuseBinge drinkingAnxietyBinge DrinkingEpigenesis GeneticMice03 medical and health sciencesBehavioral Neuroscience0302 clinical medicineRewardNeuroimmune systemmedicineAnimalsTLR4Neuroinflammationmedia_commonMice KnockoutEthanolBinge ethanol treatmentEndocrine and Autonomic SystemsAddictionAge FactorsNeurotoxicityBrainAnxiety-like behaviormedicine.diseaseEthanol preferencePrelimbic medial prefrontal cortexAdolescenceMice Inbred C57BLToll-Like Receptor 4Alcoholism030104 developmental biologySynaptic plasticityFemaleCognition DisordersPsychologyNeuroscienceMyelin Proteins030217 neurology & neurosurgeryFOSBBrain, Behavior, and Immunity
researchProduct

Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma

2011

hepatocellular carcinoma HDACi epigenetic changes.RKIP (Raf-1 Kinase Inhibitor Protein)Settore BIO/14 - Farmacologia
researchProduct

Clinical and immunological aspects of microRNAs in neonatal sepsis

2022

Abstract Neonatal sepsis constitutes a highly relevant public health challenge and is the most common cause of infant morbidity and mortality worldwide. Recent studies have demonstrated that during infection epigenetic changes may occur leading to reprogramming of gene expression. Post-transcriptional regulation by short non-coding RNAs (e.g., microRNAs) have recently acquired special relevance because of their role in the regulation of the pathophysiology of sepsis and their potential clinical use as biomarkers. ~22-nucleotide of microRNAs are not only involved in regulating multiple relevant cellular and molecular functions, such as immune cell function and inflammatory response, but have…

Epigenetic changesInflammationRM1-950BioinformaticsEpigenesis GeneticSepsisImmune systemInfant morbiditymicroRNAmedicineAnimalsHumansEpigeneticsInflammationPharmacologyNeonatal sepsisbusiness.industryInfant NewbornImmunityGeneral MedicinePrognosismedicine.diseaseMicroRNAsGene Expression RegulationNeonatal sepsisTherapeutics. Pharmacologymedicine.symptombusinessReprogrammingBiomarkersBiomedicine & Pharmacotherapy
researchProduct

Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple-negative breast canc…

2015

Raf-1 kinase inhibitor protein (RKIP) is a tumor suppressor and metastasis inhibitor, which enhances drug-induced apoptosis of cancer cells. Downregulation of RKIP may be significant in the biology of highly aggressive and drug-resistant tumors, for example triple-negative breast cancers (TNBCs). Potential causes for the low levels of RKIP expressed by SUM 159 TNBC cells were investigated in the present study. Bisulphite modification, methylation specific-polymerase chain reaction (PCR) and a TransAM NF-κB assay were performed and the results suggested that various mechanisms, including methylation of the gene promoter, histone deacetylation and nuclear factor-κB (NF-κB) activation, but not…

Cancer Researchmedicine.drug_classCell growthtriple-negative breast cancer Raf-1 kinase inhibitor protein epigenetic changes microRNA-224 nuclear factor-κBHistone deacetylase inhibitorArticlesCell cycleBiologyMolecular biologyDemethylating agentchemistry.chemical_compoundTrichostatin AOncologychemistryCancer cellmedicineCancer researchGrowth inhibitionTranscription factormedicine.drug
researchProduct

Genetic polymorphisms and epigenetics changes in human metabolizing enzymes genes to predict differential therapeutic drug effects

2013

It has been understood that genetic variability can influence individual ability to metabolize drugs (Kiyohara C. et al., 2002). In particular, sequence changes into some genes give to subject a variable capability to response to a therapy protocol, to begin a resistance toward therapeutic drugs or, on the contrary, to be more sensible to it: the genes of CYP-family, CYP2A6 and CYP2E1, are good examples. Nevertheless, gene expression can be affected either by DNA sequence mutations (polymorphisms) or by “epigenetic modifications”, such as DNA methylation of a CpG islands in a gene promoter ion (Zhu J. et al., 2009). For these reasons, it is indispensable, today, to integrate genetic analyse…

Settore BIO/18 - GeneticaCYP2E1 Polymorphisms epigenetic changes
researchProduct